Medical/Pharmaceuticals

Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform

* Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages * Based on the initial arrangements, the total invoiced amount expected to be achieved by Henlius in 2026 is ...

2026-08-17 12:34 2913

New Study Confirms Capsugel® Enprotect® Capsules Deliver Robust Gastric Integrity Under Both Fasted and Fed Conditions

SEOUL, South Korea, Aug. 14, 2026 /PRNewswire/ -- Enteric capsules are widely used to protect acid-sensitive compounds and to delay drug release until intestinal entry. However, evidence supporting their gastric integrity under physiologically relevant fed-state conditions remains limited, as mos...

2026-08-17 11:45 3001

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

SINGAPORE, Aug. 17, 2026 /PRNewswire/ -- DayOne Data Centers Limited ("DayOne"), a Singapore-headquartered global digital infrastructure platform, today launched Singapore's first Biological Data Center Prototype in collaboration with Cortical Labs and the Yong Loo Lin School of Medicine, Nation...

2026-08-17 10:00 17351

IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics

NANJING, China and SINGAPORE, Aug. 14, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ("MediSix"), a Singapore-based immune cell engineering and cell therapy company. This acquisition marks a step in IASO Bio's global...

2026-08-14 20:20 7457

SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate

* Phase 1b study will evaluate safety and pharmacokinetics of RSM01 in approximately 80 infants aged 2 weeks to 8 months * Company expands its global portfolio beyond vaccines into antibody-based preventive technologies * Growing global R&D network strengthens capabilities in next-generation...

2026-08-14 20:00 4442

ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial

SHANGHAI, Aug. 14, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has approved ziresovir (AK0529) for a phase II clinical trial in the severely ill RSV infected infant patients, including the ones in pediat...

2026-08-14 18:18 3561

/DISREGARD RELEASE: IASO Bio/

We are advised by IASO Bio that journalists and other readers should disregard the news release, IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics, issued 13-Aug-2026 over PR Newswire, as the release contained erroneous information. ...

2026-08-14 13:30 5031

Dimora Medical's Sacrum Silicone Absorbent Soft Dressing Breaks into Amazon Wound Dressings Top 3

NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, announced that its newly launchedDimora Sacrum Silicone Absorbent Soft Dressing has achieved s...

2026-08-14 01:50 3344

Innorna Nominated for 2026 Prix Galien USA Best Startup Award

HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., Aug. 13, 2026 /PRNewswire/ -- Innorna, a clinical-stage biotech company advancing RNA medicines, today announced that it has been nominated for the2026 Prix Galien USA Best Startup Award. Innorna was shortlisted in the Best Startup c...

2026-08-13 22:00 3387

Rhein Laser Unveils CELIORA®, a New Generation of Intelligent Red Light Therapy Beds

Five Wavelengths and 88,000 LED Chips Deliver the Industry's First Continuous, Dark-Line-Free Full-Body Red-Light Coverage MIAMI, Aug. 13, 2026 /PRNewswire/ -- Rhein Laser, a global developer of professional laser and photobiomodulation technologies, today announced the launch of the CELIORA® Re...

2026-08-13 21:10 2677

Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform OXFORD, England and SEOUL, South Korea, Aug. 13, 2026 /PRNewswire/ -- Optellum and Coreline Soft

2026-08-13 21:00 4313

Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona

NEW YORK and SUZHOU, China, Aug. 13, 2026 /PRNewswire/ -- Accro Bioscience, a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, today announced that it will present efficacy and safety results from a Phase 1b proof-of-concept study...

2026-08-13 19:00 3408

HMI Medical Strengthens Diagnostic Capabilities to Support Singapore's Shift Beyond Hospital Care

With the addition of Lifescan Imaging, HMI Medical now operates a network of seven diagnostic and imaging centres, enhancing access to timely diagnosis while supporting coordinated patient care across Singapore's key medical hubs. SINGAPORE, Aug. 13, 2026 /PRNewswire/ -- Health Management Interna...

2026-08-13 14:00 3530

Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers

SHANGHAI, Aug. 13, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel")http://www.angelaligner.com  said today that it will appeal the A...

2026-08-13 12:35 3839

ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis

SHANGHAI, Aug. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the Investigational New Drug (IND) application for AK0406 injection, the company's first long-acting antiviral drug‑Fc conjugate (AFC) candidate for influenza prophylaxis, has been app...

2026-08-13 09:00 4642

Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN® at Aesthetics 2026

Following REJURAN®'s TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals. GANGNEUNG, South Korea, Aug. 13, 2026 /PRNewswire/ -- PharmaResearch, the biopharmaceutical company behind REJURAN®, recently participated in Aesth...

2026-08-13 08:00 4916

VITAMIN ANGELS EXPANDS PARTNERSHIP WITH THE MINISTRY OF HEALTH OF INDONESIA TO STRENGTHEN NATIONWIDE VITAMIN A CAMPAIGN

Collaboration strengthened health worker training, communication strategies, monitoring and evaluation, and delivered 870,000 vitamin A capsules for children across Indonesia. Vitamin A can reduce child mortality by up to 24% among children ages 6 to 59 months in populations at risk of vitamin A...

2026-08-13 03:45 5108

Osara Health Marks 10 Years with Global Call to Make Cancer Support Beyond Treatment Standard

Launched to mark the company's 10th anniversary, Osara Health's Global Cancer Support Declaration has already secured signatures from healthcare professionals worldwide. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Osara Health, a global digital health company focused on the human experience of cance...

2026-08-12 23:17 3458

PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)

NANJING, China, Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The ...

2026-08-12 22:00 3497

RingConn Advances Wearable Health Research with New Study in Nature Portfolio Journal npj Digital Medicine

The study, "Large-scale bilateral cardiovascular monitoring via wearable rings," analyzes 97,559 valid ring-PPG samples from 1,810 participants, providing new insights into bilateral wearable sensing for cardiovascular monitoring. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- A major step toward overc...

2026-08-12 22:00 4972
1 ... 34353637383940 ... 642